ArticleFrontiers in digital health2026
A retrospective comparative study of ChatGPT-5.4 and DeepSeek-VL2 for C-TIRADS-based risk stratification of thyroid nodules on ultrasound images.
Article in Frontiers in digital health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background/objectives: Multimodal large language models are increasingly being explored for medical image interpretation, but their performance in thyroid nodule ultrasound assessment remains uncertain. This study compared ChatGPT-5.4 and DeepSeek-VL2 for C-TIRADS-based risk stratification of thyroid nodules using static ultrasound images. Methods: This single-center retrospective diagnostic accuracy study included 206 pathologically confirmed thyroid nodules, including 117 benign and 89 malignant nodules. For each nodule, paired transverse and longitudinal ultrasound images were analyzed by both models using the same standardized English prompt. The models generated structured outputs for C-TIRADS-related ultrasound features and estimated C-TIRADS category. Pathology served as the reference standard for malignancy, and expert-assigned C-TIRADS served as the imaging reference standard. Model-assigned C-TIRADS categories were used as ordinal risk scores. The primary analysis used C-TIRADS ≥4B as the binary positive threshold for predicting pathology-confirmed malignancy, and a sensitivity analysis used C-TIRADS ≥4A. Results: At the ≥4B threshold, ChatGPT-5.4 achieved higher accuracy, sensitivity, and specificity than DeepSeek-VL2: 70.9%, 61.8%, and 77.8% vs. 57.8%, 50.6%, and 63.2%, respectively. Its non-diagnostic rate was also lower (6.3% vs. 15.5%). In the valid-output ROC analysis, AUCs were 0.903 for expert assessment, 0.790 for ChatGPT-5.4, and 0.757 for DeepSeek-VL2; model-based ROC analyses excluded indeterminate outputs and should be interpreted as per-protocol estimates. At the C-TIRADS category level, ChatGPT-5.4 showed higher exact agreement with expert assessment than DeepSeek-VL2 (45.6% vs. 36.4%) and higher within-one-category agreement (87.6% vs. 82.2%). Feature-level analysis showed that both models performed best on echogenicity but poorly on margin and echogenic foci. At the ≥4A threshold, sensitivity increased but specificity decreased substantially for both models. Conclusions: ChatGPT-5.4 showed a more favorable performance profile than DeepSeek-VL2, but differences in sensitivity and valid-output AUC were not statistically significant. Both models remain investigational adjunctive tools and should not be used for unsupervised clinical decision-making or standalone triage.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.